Skip to main content
. Author manuscript; available in PMC: 2026 Feb 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2024 Apr 28;169(2):658–666.e3. doi: 10.1016/j.jtcvs.2024.04.008

Table 1.

Baseline characteristics stratified by donor age in unmatched cohort.

<40 years
(n=833)
≥40 years
(n=161)
P-value
Recipient characteristics
Age (years) 57 [44-64] 57 [49-65] 0.11
Female sex 177 (21.2%) 26 (16.1%) 0.14
Race 0.26
White 562 (67.5%) 120 (74.5%)
Black 173 (20.8%) 22 (13.7%)
Hispanic 79 (9.5%) 16 (9.9%)
Asian 14 (1.7%) 3 (1.9%)
Other 4 (0.5%) 0 (0.0%)
Body mass index (kg/m2) 28.5 ± 5.0 28.8 ± 4.6 0.58
Recipient blood type 0.49
A 291 (34.9%) 56 (34.8%)
AB 27 (3.2%) 3 (1.9%)
B 97 (11.6%) 14 (8.7%)
O 418 (50.2%) 88 (54.7%)
Heart failure etiology 0.099
Non-Ischemic 435 (52.2%) 72 (44.7%)
Ischemic 229 (27.5%) 53 (32.9%)
Congenital 27 (3.2%) 7 (4.3%)
Restrictive 37 (4.4%) 7 (4.3%)
Valvular 13 (1.6%) 4 (2.5%)
Hypertrophic 36 (4.3%) 4 (2.5%)
Other 16 (1.9%) 0 (0.0%)
Education level 0.37
High school 297 (36.6%) 65 (41.7%)
College 430 (53.0%) 79 (50.6%)
Graduate degree 84 (10.4%) 12 (7.7%)
Diabetes mellitus 255 (30.6%) 37 (23.0%) 0.052
Cerebrovascular accident 56 (6.7%) 11 (6.8%) 0.96
Prior cardiac surgery 359 (43.1%) 73 (45.3%) 0.60
Pretransplant dialysis 9 (1.1%) 2 (1.2%) 0.86
Total bilirubin (mg/dL) 0.87 ± 0.77 0.85 ± 0.60 0.67
Serum creatinine (mg/dL) 1.21 ± 0.47 1.26 ± 0.49 0.30
Pretransplant mechanical ventilation 4 (0.5%) 0 (0.0%) 0.38
Intensive care unit at time of transplant 276 (33.1%) 43 (26.7%) 0.11
Intravenous inotropes 253 (30.4%) 43 (26.7%) 0.35
Intra-aortic balloon pump 129 (15.5%) 16 (9.9%) 0.068
Extracorporeal membrane oxygenation 13 (1.6%) 1 (0.6%) 0.35
Impella 18 (2.2%) 3 (1.9%) 0.81
Durable ventricular assist device 228 (27.4%) 29 (18.0%) 0.013
Cardiac index (L/min/m2) 2.13 ± 0.59 2.07 ± 0.61 0.22
Donor Characteristics
Age (years) 28 [23-33] 43 [41-45] <0.001
Female 125 (15.0%) 18 (11.2%) 0.21
Race <0.001
White 647 (77.7%) 121 (75.2%)
Black 85 (10.2%) 10 (6.2%)
Hispanic 88 (10.6%) 22 (13.7%)
Asian 4 (0.5%) 7 (4.3%)
Other 9 (1.1%) 1 (0.6%)
Body mass index (kg/m2) 27.5 ± 6.6 28.8 ± 5.7 0.017
Blood type 0.20
A 252 (30.3%) 46 (28.6%)
AB 2 (0.2%) 0 (0.0%)
B 73 (8.8%) 7 (4.3%)
O 506 (60.7%) 108 (67.1%)
Mechanism of death <0.001
Trauma 378 (45.4%) 50 (31.1%)
Cerebrovascular 59 (7.1%) 26 (16.1%)
Drug overdose 193 (23.2%) 37 (23.0%)
Other 203 (24.4%) 48 (29.8%)
Cocaine use 215 (27.7%) 46 (33.3%) 0.18
Diabetes mellitus 15 (1.8%) 9 (5.7%) 0.004
Hypertension 245 (29.4%) 69 (42.9%) <0.001
Serum creatinine (mg/dL) 1.12 ± 1.40 1.28 ± 2.03 0.24
Graft left ventricular ejection fraction <50% 10 (1.2%) 1 (0.6%) 0.52
Positive Cytomegalovirus serology 465 (56.6%) 81 (51.3%) 0.21
Hepatitis C 67 (8.0%) 19 (11.8%) 0.12
Matching and Transplant Characteristics
Sex matched 703 (84.4%) 139 (86.3%) 0.53
Race matched 485 (58.2%) 96 (59.6%) 0.74
Human leukocyte antigen matched (≤3 loci mismatch) 93 (11.2%) 15 (9.3%) 0.49
ABO matched 723 (86.8%) 138 (85.7%) 0.71
Cytomegalovirus matched 401 (48.8%) 95 (60.1%) 0.009
Waitlist time (days) 33 [9-182] 37 [11-200] 0.49
Donor distance to transplanting center (nautical miles) 340 [136-566] 237 [51-524] 0.005
Graft preservation time (hours) 5.0 [3.5-6.5] 4.4 [2.7-6.2] 0.040
Redo transplantation 17 (2.0%) 0 (0.0%) 0.067
Status at time of transplantation 0.008
1 22 (2.6%) 0 (0.0%)
2 288 (34.6%) 51 (31.7%)
3 148 (17.8%) 22 (13.7%)
4 254 (30.5%) 52 (32.3%)
5 1 (0.1%) 2 (1.2%)
6 120 (14.4%) 34 (21.1%)